India  

Syringe-makers look to ramp up stocks for Covid vaccine

IndiaTimes Friday, 16 October 2020 ()
0
shares
ShareTweetSavePostSend
 
Video Credit: ANI - Published
News video: Equity indices tumble amid weak global cues, banking and IT stocks suffer

Equity indices tumble amid weak global cues, banking and IT stocks suffer 01:22

Equity benchmark indices tumbled over half per cent during early hours on October 14 tracking Asian peers as halted COVID-19 vaccine trials soured investor risk appetite. Besides, the International Monetary Fund (IMF) revised its projection of contraction in India's GDP for current fiscal year to...

💡 newsR Knowledge: Other News Mentions

Coronavirus disease 2019 Coronavirus disease 2019 Infectious respiratory disease caused by severe acute respiratory syndrome coronavirus 2

Coronavirus in numbers: UK death toll rises by 280 [Video]

Coronavirus in numbers: UK death toll rises by 280

The Government said a further 280 people had died within 28 days of testingpositive for Covid-19 as of Thursday. This brings the UK total to 45,955.

Credit: PA - Press Association STUDIO    Duration: 00:34Published

Bihar Assembly Elections 2020: Despite COVID, voter turnout higher in 1st phase than 2015, 2019

The voting percentage was more than that of 2015 Assembly elections which saw 54.94 per cent voters exercise their franchise and also more than the 2019 Lok..
DNA

COVID-19: Centre advises states/UTs to gear up 'testing, tracking and treatment' strategy during festivities

Bhushan has advised these states and UTs to ensure enforcement of precautionary measures like maintaining social distancing, sanitisation, wearing of masks,..
DNA

Strengthen testing, tracking, treatment strategy during festivals: Centre to Delhi, Kerala, Bengal

The Centre on Thursday advised Delhi, Kerala and West Bengal, witnessing a significant rise in coronavirus cases, to gear up the testing, tracking and treatment..
IndiaTimes

You Might Like


Related videos from verified sources

Covid Stocks: Where Are the Winners in the 'New Normal?' [Video]

Covid Stocks: Where Are the Winners in the 'New Normal?'

Which stocks stand to benefit most as the coronavirus pandemic continues?

Credit: The Street     Duration: 01:10Published
What goes into making a vaccine? [Video]

What goes into making a vaccine?

Right now, there is no FDA-approved vaccine for COVID-19, but researchers are racing to create one.

Credit: Idaho On Your Side     Duration: 01:51Published
U.S. Reaches Record High With Over 74,000 New Covid-19 Cases Nationwide Everyday [Video]

U.S. Reaches Record High With Over 74,000 New Covid-19 Cases Nationwide Everyday

Over 40 states are reporting an increase in COVID-19 cases, adding an average of more than 74,000 cases to the national total everyday. Veuer’s Maria Mercedes Galuppo has the story.

Credit: Veuer     Duration: 01:11Published

Related news from verified sources

COVID-19: Frontline doctors not paid for three months now

COVID-19: Frontline doctors not paid for three months now
With no salaries coming for last three months the* Covid 19* front line warriors are left in the lurch. Already 450 plus doctors across the country have lost...
Mid-Day

Mumbai: Post-COVID cornea collection drops 78 per cent

Mumbai: Post-COVID cornea collection drops 78 per cent
The pandemic has seen a massive drop in cornea collection and transplant in the country, majorly because of the Union Ministry of Health's directive against home...
Mid-Day

mid-day special: Mumbai sees few casualties among those with both TB and COVID-19

mid-day special: Mumbai sees few casualties among those with both TB and COVID-19
During the pandemic, while symptoms like cough and fever are being flagged as suspected cases of COVID-19, city doctors are also dealing with cases where...
Mid-Day


Tweets about this